CDT CONDUIT PHARMACEUTICALS INC.

Nasdaq www.conduitpharma.com


$ 2.22 $ -0.18 (-7.23 %)    

Thursday, 13-Nov-2025 17:09:46 EST
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 2.31
$ 2.36
$ 2.25 x 1
$ 2.57 x 4,000
-- - --
$ 2.30 - $ 2,198.40
50,192
na
3.76M
$ -0.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-28-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-12-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 04-16-2024 12-31-2023 10-K
9 11-20-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-28-2023 12-31-2022 10-K
13 11-07-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-17-2022 03-31-2022 10-Q
16 03-29-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-earlier-cdt-equity-acquires-additional-926-btc-for-1m-as-part-of-ongoing-crypto-treasury-strategy-cdts-total-bitcoin-holdings-now-stand-at-179090111-btc

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced the acquisition of 9.25648743 Bitcoin (&...

 cdt-equity-announces-1-for-8-reverse-stock-split-effective-october-10-2025

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), announces that its board of directors has approved a 1-f...

 cdt-equity-announces-strategic-purchase-of-865-bitcoin-for-1m-at-an-average-price-of-115285-per-btc

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced the strategic acquisition of 8.65252366 B...

 cdt-equity-identifies-new-biological-target-and-therapeutic-use-for-azd1656-through-ai-driven-drug-repurposing

CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announces that it has successfully identified a new...

 conduit-pharma-intends-to-change-its-name-to-cdt-equity-inc

Name change to CDT Equity Inc. reflects evolution of strategy and focus on identifying, enhancing, and advancing high-potential...

 conduit-pharmaceuticals-files-new-four-patents-related-to-assets-azd1656-and-azd5658

Includes Conduit's first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION